Illumina, Inc.
American biotechnology company
Follow Illumina, Inc. on Notably News to receive short updates to your email — rarely!
| March 4 2025 | China's Ministry of Commerce prohibited the export of Illumina gene sequencers to China. |
| February 4 2025 | China placed Illumina on its 'Unreliable Entities List' in response to U.S. tariffs. |
| September 2023 | Jacob Thaysen from Agilent Technologies was appointed as Illumina's CEO. |
| June 2023 | Francis deSouza resigned as CEO, replaced by interim CEO Charles Dadswell, and Stephen Macmillan was named non-executive Chairman of the Board. |
| September 2022 | Illumina launched NovaSeq X and NovaSeq X Plus, with the X Plus capable of sequencing 20,000 genomes per year. |
| May 6 2022 | A jury in the U.S. District Court for the District of Delaware found Illumina willfully infringed two patents owned by Complete Genomics, awarding approximately $334 million in past damages and invalidating three of Illumina's own patents. |
| March 2022 | Illumina filed a trade secrets lawsuit against Helmy Eltoukhy and Amir Talasaz, co-founders of Guardant, alleging theft of trade secrets. Guardant responded by calling the lawsuit 'frivolous and retaliatory' and suggested it was a strategic move to suppress market competition and in response to concerns about the Illumina-Grail merger. |
| August 18 2021 | Illumina completed its acquisition of Grail, despite ongoing investigations by the US FTC and EU European Commission. |
| 2020 | Dr. Monib Zirvi filed a FOIA case in New Jersey seeking unredacted copies of key NIH grants that Illumina filed early in its existence. |
| September 2020 | Illumina announced a proposed cash and stock deal to acquire Grail for $8 billion. |
| February 2020 | Illumina filed a patent infringement suit against BGI regarding its 'CoolMPS' sequencing products. |
| 2018 | Dr. Monib Zirvi filed a lawsuit in the Southern District of New York against Illumina and key employees, claiming unauthorized incorporation of ZipCode DNA sequences invented in the Barany Lab. The suit was ultimately dismissed. |
| September 2017 | Both Cornell University and Life Technologies requested a review of the settlement, with Cornell accusing Illumina and Life Technologies of misrepresentation and fraud. |
| April 2017 | The Cornell University and Life Technologies lawsuit against Illumina was initially settled without any finding of fault. |
| August 2016 | Illumina and Oxford Nanopore Technologies settled their patent lawsuit. |
| July 5 2016 | Jay Flatley transitioned from CEO to executive chairman, with Francis deSouza becoming CEO. |
| February 2016 | Illumina filed a patent lawsuit against Oxford Nanopore Technologies, claiming patent infringement on biological nanopore sequencing systems. |
| January 2015 | William Noon, an in-house attorney at Illumina, filed a FOIA request for 4 key NIH grants. |
| 2012 | Verinata Health initiated a patent lawsuit against Ariosa Diagnostics, with Illumina later joining the suit after acquiring Verinata in 2013. |
| January 11 2011 | Illumina acquired Epicentre Biotechnologies, based in Madison, Wisconsin. |
| 2010 | Illumina obtained FDA approval for its BeadXpress system to be used in clinical tests, marking its entry into clinical genetic testing. |
| 2010 | Cornell University and Life Technologies filed a lawsuit against Illumina, alleging patent infringement on eight patents related to microarray products. |
This contents of the box above is based on material from the Wikipedia article Illumina, Inc., which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.